Macrophage-targeting Antisenescence nanomedicine enables in-Situ NO induction for Gaseous and antioxidative atherosclerosis intervention
Senescent-endothelial cells significantly accelerate atherosclerosis progression, making the mitigation of cellular aging a promising strategy for treating the disease. Nitric oxide (NO), a low molecular weight and lipophilic gas, has been shown to penetrate cell membranes effectively and delay cell...
Saved in:
| Main Authors: | Yuanyuan Peng, Wei Feng, Hui Huang, Yu Chen, Shaoling Yang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KeAi Communications Co., Ltd.
2025-06-01
|
| Series: | Bioactive Materials |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2452199X25000805 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nanomedicine in cardiovascular and cerebrovascular diseases: targeted nanozyme therapies and their clinical potential and current challenges
by: Yanhua Jiang, et al.
Published: (2025-07-01) -
Recent Advances in Nanozymes for the Treatment of Atherosclerosis
by: Zou Z, et al.
Published: (2025-07-01) -
Curcumin-loaded nanoscale coordination polymers for ROS scavenging and anti-inflammatory therapy in atherosclerosis
by: Song Ding, et al.
Published: (2025-10-01) -
Antisenescence therapies for age‐related bone loss: Target factors, medicines, biomedical materials
by: Qiyue Zhu, et al.
Published: (2025-06-01) -
Microenvironment Self-Adaptive Ce-Ag-Doped Mesoporous Silica Nanomaterials (CA@MSNs) for Multidrug-Resistant Bacteria-Infected Diabetic Wound Treatment
by: Wuhao Yang, et al.
Published: (2025-04-01)